Portfolio company
RetMap
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
RetMap develops electroretinography sensors and electrodes for clinicians to diagnose neurodegenerative eye conditions in human and veterinary patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neuro Modulation Artificial Retina
This company develops a high-acuity spherical bionic retinal implant to restore vision for patients with retinitis pigmentosa or age-related macular degeneration.
RhyGaze
This biotechnology company develops optogenetic gene therapies to restore vision for patients with retinal diseases causing blindness.
eye2gene
Eye2Gene develops an AI-powered platform that analyses retinal imaging to accelerate genetic diagnosis of inherited diseases for pharmaceutical companies and eye care professionals.
EarlySight
EarlySight develops a cellular-level retinal imaging camera and AI software for eye doctors to detect and monitor ophthalmic diseases at microscopic scales.
neuroClues
This company develops portable eye-tracking medical devices and AI software for clinicians to identify neurological disorders through ocular biomarkers.
GelMEDIX
GelMEDIX develops injectable hydrogel scaffolds and regenerative cell therapies to treat degenerative ocular diseases such as geographic atrophy for patients with vision loss.
AI Optics
This company develops handheld retinal imaging devices and artificial intelligence software for healthcare providers to screen and diagnose eye diseases at the point of care.
Ocuwell
This company develops portable corneal topography systems and diagnostic software for clinicians and opticians to improve global access to eye care.
